Ana C Montagud
Biographic Data
| ID | 7763288 |
|---|---|
| NAME | Ana C Montagud |
| GIVEN NAMES | Ana C |
| FAMILY NAME | Montagud |
| SIGNATURE | MONTAGUD A C |
| AFFILIATIONS | Hospital Quirónsalud Barcelona |
| ORCID | 0000-0002-0647-0551 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Seroprevalence against Sars-CoV-2 after booster vaccination in a prison in Alicante (Spain)
Background: Confinement conditions in prison communities are associated with increased susceptibility to infectious outbreaks. The COVID-19 pandemic has been characterized by high transmissibility and clinical severity resulting in a high number of infections and deaths worldwide. Vaccination has been a crucial tool in mitigating its devastating effects. The aim of this study is to asses the prevalence of antibodies against the Spike protein of S…
Assessment of Sars-CoV-2 neutralizing antibody persistence using LFIC
The primary immunization against SARS-CoV-2 has yielded protection rates of up to 95%. The evolution of the original strain of SARS-CoV-2 towards emerging variants which have higher transmissibility, severity of disease and greater viral escape, have promoted the necessity of vaccine booster doses. The third dose of the vaccine provides protection, but its long-term durability remains uncertain. Our aim was to know the vaccine coverage at the Uni…
Seroprevalence Study and Cross-Sectional Survey on Covid-19 for a Plan to Reopen the University of Alicante (Spain)
The implementation of strategies to mitigate possible cases of COVID-19 were addressed at the University of Alicante for the safe reopening of the 2020/2021 academic year. To discover the prevalence of immunity against SARS-CoV-2, a study was designed using a rapid immunoassay test (carried out between 6 and 22 July 2020), and in addition a cross-sectional survey was conducted on risk factors, symptoms, predisposition for becoming vaccinated, and…
No prominent works on this page.
Seroprevalence Study and Cross-Sectional Survey on Covid-19 for a Plan to Reopen the University of Alicante (Spain)
The implementation of strategies to mitigate possible cases of COVID-19 were addressed at the University of Alicante for the safe reopening of the 2020/2021 academic year. To discover the prevalence of immunity against SARS-CoV-2, a study was designed using a rapid immunoassay test (carried out between 6 and 22 July 2020), and in addition a cross-sectional survey was conducted on risk factors, symptoms, predisposition for becoming vaccinated, and…
Seroprevalence against Sars-CoV-2 after booster vaccination in a prison in Alicante (Spain)
Background: Confinement conditions in prison communities are associated with increased susceptibility to infectious outbreaks. The COVID-19 pandemic has been characterized by high transmissibility and clinical severity resulting in a high number of infections and deaths worldwide. Vaccination has been a crucial tool in mitigating its devastating effects. The aim of this study is to asses the prevalence of antibodies against the Spike protein of S…
Assessment of Sars-CoV-2 neutralizing antibody persistence using LFIC
The primary immunization against SARS-CoV-2 has yielded protection rates of up to 95%. The evolution of the original strain of SARS-CoV-2 towards emerging variants which have higher transmissibility, severity of disease and greater viral escape, have promoted the necessity of vaccine booster doses. The third dose of the vaccine provides protection, but its long-term durability remains uncertain. Our aim was to know the vaccine coverage at the Uni…
COVID-19 Clinical Research Studies (3 works) · SARS-CoV-2 and COVID-19 Research (3 works) · Serology (3 works) · Antibody (2 works) · Demography (2 works) · Environmental health (2 works) · Immunology (2 works) · Internal Medicine (2 works) · Medicine (2 works) · SARS-CoV-2 detection and testing (2 works)